Tamoxifen-resistant MCF-7 Breast Cancer Cell Line

MCF-7 cells serve as a prototypic model system for human breast cancer and their response to secretive endocrine response modifiers (SERM) therapy. MCF-7 cells, upon long term exposure to tamoxifen, acquire tam-resistance and continue to grow in the presence of tamoxifen. Description (Set) Proposed Use (Set) This invention provides a cell-based model, both in vitro and in vivo, for tam-resistant breast cancer, allows the testing of alternate therapies to tam-resistant breast cancer, or the high-throughput testing of drugs that might synergize with hormone based therapies.

Inventor(s): Sukumar, Saraswati V.

Type of Offer: Licensing



« More Medical Patents

---